Clinical Trials Browser

Prostatic Neoplasms, Sedentary Behavior

NCT07398820 2026-02-10

IMPACT OF SEDENTARY BEHAVIOR IN THE HOMEOSTASIS OF THE DIGESTIVE ECOSYSTEM

Completed

80 enrolled

Gastrointestinal

Motor Activity, Colorectal Neoplasms, Sedentary Behavior

NCT06182163 2026-02-02

ReSeT in ALL

Phase NA Completed

20 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Sedentary Behavior

NCT05873296 2025-12-10

Health Education for Women With Breast Cancer

Phase NA Completed

28 enrolled

Breast

Breast Neoplasms, Health Education, Sedentary Behavior

NCT05582889 2025-11-10

Move For Your Health for Older Cancer Survivors

Phase NA Completed

64 enrolled 42 charts

Motor Activity, Sedentary Behavior

NCT06125964 2025-08-14

eMOTION Formative Study

Phase NA Completed

47 enrolled 24 charts

Other

Motor Activity, Neoplasms, Obesity, Overweight, Sedentary Behavior

NCT05176756 2025-08-01

ALLSTAR

Phase NA Completed

150 enrolled

BreastGenitourinary

Breast Neoplasms, Cardiovascular Diseases, Motor Activity, Prostatic Neoplasms, Sedentary Behavior

NCT03982095 2025-06-20

PCa_LS

Completed

40 enrolled

Genitourinary

Motor Activity, Prostatic Neoplasms, Health Behavior, Sedentary Behavior

NCT03987217 2025-05-14

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

Phase EARLY_PHASE1 Completed

73 enrolled

Genitourinary

Fatigue, Prostatic Neoplasms, Sedentary Behavior

NCT05737745 2025-05-09

FitEx for Endometrial Cancer Survivors: Initial Efficacy

Phase NA Completed

111 enrolled 7 charts

GynecologicOther

Obesity, Endometrial Neoplasms, Sedentary Behavior

Clinical Trials

Fatigue Interventions in Cancer (Exercise Intervention)

IMPACT OF SEDENTARY BEHAVIOR IN THE HOMEOSTASIS OF THE DIGESTIVE ECOSYSTEM

ReSeT in ALL

Health Education for Women With Breast Cancer

Move For Your Health for Older Cancer Survivors

eMOTION Formative Study

ALLSTAR

PCa_LS

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

FitEx for Endometrial Cancer Survivors: Initial Efficacy